BSE · ADVIKLA
Advik Laboratories Ltd.
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,898
of 5,040 stocks
▼ 511W
Peak #4,847 · 02 Oct 2026
Operating in Healthcare, Advik Laboratories Ltd. trades at an undemanding earnings multiple, has a subdued return on equity, and has promoters holding 36%.
Market Cap
3.98 Cr
P/E Ratio
3.92
P/B Ratio
52.00
ROE
-1,489.05%
ROCE
-363.39%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | Rs 0 | Rs 0 | Rs 0 | Rs 0 |
| Net Profit | -23.80 L | -35.93 L | -22.03 L | -22.01 L |
| EPS | 0.12 | 0.19 | 0.12 | 0.12 |
| Operating Profit | -23.74 L | -36.92 L | -22.94 L | -22.98 L |
Shareholding pattern
Promoter
35.89%
Public
64.11%
PUBLIC BREAKDOWN
DII
0.58%
Individuals
38.07%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 21 Mar 2022 | Other | E.G.M. |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.